Key result
A high neutrophil-to-lymphocyte ratio (≥ 4.5) was associated with significantly higher cumulative incidences of cardiovascular and all-cause mortality in patients on peritoneal dialysis (both P<0.01).
Why the study?
Does a high neutrophil-to-lymphocyte ratio predict cardiovascular and all-cause mortality in patients undergoing peritoneal dialysis?
Cohort (n=86)
Does a high neutrophil-to-lymphocyte ratio predict cardiovascular and all-cause mortality in patients undergoing peritoneal dialysis?
An elevated neutrophil-to-lymphocyte ratio (≥ 4.5) serves as a significant prognostic marker for arterial stiffness and mortality in patients undergoing peritoneal dialysis.
May stratify mortality risk among peritoneal dialysis patients; hypothesis-generating and requires prospective validation before clinical adoption.
BACKGROUND/AIMS: Chronic inflammation is associated with increased risk of cardiovascular death in patients with end-stage renal disease (ESRD). Although elevated neutrophil-to-lymphocyte ratio (NLR), a novel inflammatory marker, has been shown to predict cardiovascular disease and all-cause mortality in the general population, limited evidence is available for its role in ESRD. METHODS: We enrolled 86 patients undergoing peritoneal dialysis (PD) for a 36-month follow-up to investigate the association between the NLR and arterial stiffness markers, namely, carotid-femoral pulse wave velocity (cfPWV) and carotid augmentation index (AIx), and mortality in PD patients. The primary endpoints were cardiovascular mortality and all-cause mortality. Kaplan-Meier curves were used to show the cumulative incidence of cardiovascular mortality and all-cause mortality. RESULTS: High NLR was found to be a predictor of increased cfPWV (β = 1.150; P < 0.001) and AIx (β = 3.945; P < 0.001) in patients on PD. Patients with higher NLR had lower survival during follow-up. Kaplan-Meier curves showed that the cumulative incidences of both cardiovascular mortality and all-cause mortality were significantly higher in patients with NLR ≥ 4.5 (both P < 0.01). CONCLUSION: Our results suggest that high NLR is independently associated with arterial stiffness and predicts cardiovascular and all-cause mortality in PD patients.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2018) conducted a cohort in End-stage renal disease undergoing peritoneal dialysis (n=86). High neutrophil-to-lymphocyte ratio (NLR ≥ 4.5) vs. Lower neutrophil-to-lymphocyte ratio (NLR < 4.5) was evaluated on Cardiovascular mortality and all-cause mortality (p=<0.01). A high neutrophil-to-lymphocyte ratio (≥ 4.5) was associated with significantly higher cumulative incidences of cardiovascular and all-cause mortality in patients on peritoneal dialysis (both P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: